Oral (pre-recorded) General HPB |
|
OG02 General HPB: Imaging |
Selection of Presentations from Abstract Submissions |
OG02-01 | Development and Improvement of Real-Time Navigation System for Laparoscopic Hepatectomy Tsuyoshi Igami, Japan
T. Igami, T. Ebata, Y. Yokoyama, T. Mizuno, J. Yamaguchi, S. Onoe, N. Watanabe, M. Nagino Division of Surgical Oncology, Department of Surgery, Nagoya University Graduate School of Medicine, Japan
Introduction: We are going to try development of
real-time navigation system for laparoscopic hepatectomy, which resembles a car
navigation system. We report our real-time navigation system and surgical
procedure. Methods: Virtual images are reconstructed
using “New-VES” system developed by Nagoya University Graduate School of Information
Science. These images correspond to maps of car navigation
system. Some of patient's body parts are registered in virtual images using a magnetic position sensor. Patient's body after registration
corresponds to The Earth. A transmitter for magnetic position sensor, which
corresponds to an artificial satellite, is placed about 30cm above patient's
body. A micro magnetic sensor, which corresponds to GPS antenna, fixes on the
handling part of laparoscope.Fiducial registration error (FRE) is utilized to evaluate accuracy of
real-time navigation system.
Results: We performed laparoscopic hepatectomy using this
system in 21 patients. Mean FRE of initial
5 patients was 17.7mm. First improvement was that MDCT
were taken using radiological markers for registration of body parts. Mean FRE
of the 8 patients who utilized first improvement was 10.2mm and decreased (p = 0.014). Second improvement was that a micro magnetic
sensor as an intraoperative body position sensor was fixed on the right-sided
chest wall and meant that pre- and post- operative FRE was similar due to an
intraoperatively automatic correction of gap of body position. Preoperative and
postoperative mean FRE of the 8 patients who utilized second improvement were
11.1mm and 10.1mm (p = 0.250).
Conclusions: Our real-time navigation system can assist
laparoscopic hepatectomy. |
OG02-03 | 18Fluorodeoxygluocose Uptake Portends Poorer Prognosis in Grade 2 Gastroenteropancreatic Neuroendocrine Neoplasms: Time to Rethink Imaging Strategies? Prasad Pande, India
P. Pande, G. Desai, R. Shah, P. Jagannath Lilavati Hospital and Research Centre, India
Introduction: Grade-2
neuroendocrine neoplasms (G2 NENs) (Ki-67 index 3-20%) are diverse entities
with diagnostic and therapeutic challenges. 18fluorodeoxyglucose (18FDG) uptake
in these lesions is a marker of proliferation irrespective of the Ki-67 index.
This study analyses survival patterns in G2 NENs with 18FDG positive lesions.
Methods: Retrospective
analysis of prospectively entered data of NENs revealed 64 cases of G2 NENs at
our specialized hepatopancreatobiliary centre. These were divided into 2
groups, those with 18FDG-avid lesions (group A) and those without (group B).
Results: 37 (57.8%) out of 64 patients were in group A. 21
(32.8%) of these presented with metastatic disease, and liver was the most
common metastatic site (16 patients, 25%) followed by lymph nodes (12 patients,
18.75%). 10 (15.6%) out of 27 patients in group B had metastatic disease, and
lymph nodes (8 patients, 12.5%) were the commonest site followed by liver (4
patients, 6.25%). 17 (26.5%) patients in group A underwent curative or
debulking surgery, compared to 21 (32.8%) of group B. Median recurrence-free
and overall survival in group A was 14.7 months and 31.4 months, and that in
group B was 29.2 months and 108.1 months, respectively. Mortality was 9
patients (14.06%) in group A, and 3 (4.6%) in group B.
Conclusion: 18FDG-avid G2 NENs
more commonly present with metastatic disease, are less frequent surgical
candidates with poorer survival. Adding 18FDG-PET scan to the diagnostic algorithm
of G2 NENs in addition to Somatostatin receptor-based imaging may improve
outcomes by selecting patients for aggressive Cisplatin-based chemotherapy.
Parameter | Group A (18-FDG positive) | Group B (18-FDG negative) | Number of patients | 37 (57.8%) | 27 (42.1%) | DOTA positive (dual positive) | 16 (25%) | 27 (42.1%) | Liver metastases at presentation | 16 (25%) | 4 (6.25%) | Curative/debulking resection | 17 (26.5%) | 21 (32.8%) | Everolimus {First line for G2} | 24 (37.5%) | 10 (15.6%) | Eto-Cis {First line for high grade G2/G3} | 8 (12.5%) | 0 | Cap-Tem {Second line G2/G3} | 12 (18.75%) | 8 (12.5%) | Recurrence free/ Overall survival | 14.7/31.4 months | 29.2/108.1 months | Mortality | 9 (14.06%) | 3 (4.6%) |
[Comparison of the two groups of Grade 2 NENs] |
OG02-04 | Systematic Scoping Review of the Relationship between Molecular Profile and Radiomics of Colorectal Liver Metastases (CRLM) Atandrila Das, Australia
A. Das Peter MacCallum Cancer Centre, `Melbourne, Australia
Introduction: Radiomics
is an emerging field in medical research, with the main purpose to aid
decision-making and outcome prediction for clinicians. We present a systematic scoping review of the relationship between molecular profile and radiomics of CRLM. Methods: The
search was performed in PubMed and Embase. Screening of identified articles was undertaken according to PRISMA flow chart. Inclusion criteria were colorectal
liver metastases, imaging feature, molecular profile, radiomics/radiogenomics. Results: The search identified 966 articles of which
960 were excluded. Additional two articles were included from chain search (table 1). The
findings of this review suggests a correlation between CRLM molecular profile and radiomics. Most of
the studies identified were looking at FDG PET (four articles), followed by CT
(three articles) and MRI (one article). The most frequently investigated
molecular profile was RAS mutation. Statistically significant correlations
between molecular profile and imaging features were found for all three
mentioned imaging modalities.
Regarding
FDG PET, statistically significant correlations were found between SUV and
KRAS, GLUT1, Ki67, p53, PKM2 and HIF1-α.
Regarding
CT, statistically significant correlations were found between MICA A 5.1 and a
better tumour morphology as well as between RAS
and optimal morphologic response.
Regarding
MRI, statistically significant correlations were found between ADC and BCL-2,
Ki67 and VEGF-A. Conclusion: This
systematic review presents eight studies that show correlations between CRLMs
imaging features and molecular profile, suggesting that CRLM molecular profile
seem to influence radiomic findings, which has the potential
to facilitate decision making and care of patients by clinicians. |
|